Hoplite Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Foods
USFD
|
+$49.8M |
| 2 |
Frontdoor
FTDR
|
+$34M |
| 3 |
Medifast
MED
|
+$33.3M |
| 4 |
Elanco Animal Health
ELAN
|
+$30.5M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$28.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$55.7M |
| 2 |
Autodesk
ADSK
|
+$33.2M |
| 3 |
Adobe
ADBE
|
+$25.9M |
| 4 |
Henry Schein
HSIC
|
+$25.8M |
| 5 |
PepsiCo
PEP
|
+$24.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.41% |
| 2 | Consumer Discretionary | 23.19% |
| 3 | Consumer Staples | 13.78% |
| 4 | Communication Services | 8.85% |
| 5 | Materials | 3.06% |
Similar funds
Hoplite Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Hoplite Capital Management held 36 positions worth $836M, up 58% from $530M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Hoplite Capital Management deployed $243M of net new capital in Q1 2019, opening 16 new positions and adding to 4 existing holdings. Its largest new stake was US Foods: 1,450,926 shares worth $50.7M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Agilent Technologies, an estimated $20.7M trimmed.
- Hoplite Capital Management's largest Q1 2019 buy was US Foods: 1,450,926 shares worth $50.7M.
- Hoplite Capital Management added most to UnitedHealth in Q1 2019, an estimated $18.2M increase.
- Hoplite Capital Management's biggest Q1 2019 reduction was Agilent Technologies, cutting an estimated $20.7M.
- Hoplite Capital Management fully exited Walmart Inc in Q1 2019, selling an estimated $55.7M.
- Hoplite Capital Management's ten largest holdings make up 61% of its $836M portfolio in Q1 2019.
- Hoplite Capital Management opened 16 new positions and closed 9 in Q1 2019.
- Hoplite Capital Management's portfolio value rose 58% quarter-over-quarter to $836M.
Based on Hoplite Capital Management's 13F filing for Q1 2019, filed 15 May 2019.